Acobiom is specialized in the discovery of new Biomarkers and the development of innovative Diagnostics focused on personalized medicine applications.
This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as new diagnostics associated with treatments, especially in cancer, neurodegenerative and infectious diseases

Biomarkers and companion diagnostics in your drug development process

The strategy is to associate new therapies with innovating diagnostics and new biomarkers to determine the sub-population of patients the most likely to benefit from these new therapies

Customized omic services for your researches and your clinical trials

Based on its over 15 years experience, Acobiom provides a wide range of omic services. The objective: making sense to biological data

Bioinformatics and biostatistics bringing more value to your omic data

Acobiom provides state-of-art bioinformatic and biostatistic analyses able to analyze genomic and transcriptomic data obtained through high throughput sequencing (NGS) and qPCR systems